View Post

The Human Vaccines Project, Vanderbilt And Illumina Join Forces To Decode The Human Immunome

In In The News by Barbara Jacoby0 Comments

From: PR Newswire The Human Vaccines Project and Vanderbilt University Medical Center today announced that they joined forces with Illumina, Inc., to decipher the human immunome, the genetic underpinnings of the immune system. Illumina will provide the genetic sequencing technologies and expertise required to process the massive amounts of data required to decode the human immunome. The Human Vaccines Project …

View Post

Gut bacteria ‘may help drugs fight cancer’

In In The News by Barbara Jacoby0 Comments

By: James Gallagher From: bbc.com Bacteria living deep inside the digestive system seem to alter how cancer drugs work, a study suggests. Immunotherapies – which harness the body’s own defences to fight tumours – can clear even terminal cancer in a small proportion of patients. However, a small study by the University of Texas found those harbouring a more diverse …

View Post

3 Primary Ways Researchers Are Combatting Cancer

In In The News by Barbara Jacoby0 Comments

By: Sean Williams From: madison.com Among the countless ailments a person can be diagnosed with, cancer is arguably the scariest. Worse yet, the odds of developing cancer are probably higher than many realize. Data from the U.S. National Cancer Institute’s Surveillance Epidemiology and End Results database between 2010 and 2012 shows that men have about a 42% chance of developing cancer …

View Post

Cancer doctors face next drug challenge

In In The News by Barbara Jacoby0 Comments

By: David Crow From: ft.com Originally published on June 1, 2016 More than 30,000 doctors and scientists will gather in Chicago this weekend for the biggest annual meeting of cancer experts, organised by the American Society of Clinical Oncologists (Asco). They will be joined by healthcare investors and pharmaceuticals executives from the largest companies — such as Johnson & Johnson …

View Post

Cancer Therapy: An Evolved Approach – Scientific American

In In The News by Barbara Jacoby0 Comments

By: Cassandra Willyard From: scientificamerican.com About six years ago, Alberto Bardelli fell into a scientific slump. A cancer biologist at the University of Turin in Italy, he had been studying targeted therapies—drugs tailored to the mutations that drive the growth of a tumour. The strategy seemed promising, and some patients started to make dazzling recoveries. But then, inevitably, their tumours …

View Post

This Pancreatic Cancer Breakthrough Is Big News

In In The News by Barbara Jacoby0 Comments

From: fool.com According to the American Cancer Society’s “2015 Cancer Facts & Figures” report, nearly 1.66 million Americans were expected to be diagnosed with cancer in 2015, while more than 589,000 cancer sufferers were expected to die of the disease. Cancer has become the second-leading cause of death in the U.S., trailing only heart disease, and its rising incidence rate …

View Post

​One of the coolest ideas ever to treat cancer is being developed right in Charlestown

In In The News by Barbara Jacoby0 Comments

By: Don Seiffert From: bizjournals.com A year ago, Ziopharm was scarcely known in the biotech world, having recently moved from New York City to Charlestown just a couple years after one of its drugs failed a late-stage trial. Over the course of 2015, the company attracted worldwide notice for its early-stage treatments for cancer. In particular, attention has been on …

View Post

Pfizer, Bristol revive cancer drugs that rev up immune system

In In The News by Barbara Jacoby0 Comments

By: Bill Berkrot From: reuters.com Some of the most heralded new cancer drugs fight the disease by removing brakes on the immune system. Now a few leading drugmakers are paying attention to a second, opposing force: medicines that accelerate the immune system’s attack. Pfizer Inc, which is lagging rivals in the lucrative field of cancer immunotherapies, has been the first …

View Post

The Coming Wave of New Cancer Fighting Drugs

In In The News by Barbara Jacoby0 Comments

By: Caroline Chen From: bloomberg.com The hottest area in cancer drugs is going mainstream this year. If 2014 proved that the most promising new group of oncology drugs in generations could work, 2015 brings a crowded field that sees winners and losers in a market eventually worth $30 billion a year or more in the next decade. The treatments, known …

More than 14 million survived cancer

In In The News by Barbara Jacoby0 Comments

By: Tom Corwin From: chronicle.augusta.com Betty Wells didn’t need to be told she faced long odds for survival in March 2002 after she was diagnosed with ovarian cancer that had already spread across her abdomen. “No one ever gave me a specific time I could live or anything like that,” said Wells, 88. “But I was knowledgeable enough to know.” …